Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › IMMX
EVENTIDE ASSET MANAGEMENT, LLC position in IMMX
IMMIX BIOPHARMA INC · Health Care
EVENTIDE ASSET MANAGEMENT, LLC reported holding 5,186,534 shares of IMMX (IMMIX BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$54.0M, representing 0.76% of its reported portfolio and ranking #40 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed IMMX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How EVENTIDE ASSET MANAGEMENT, LLC's IMMX position evolved
EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in IMMX in Q4 2025 at 2,549,019 shares (US$13.3M). The position peaked in Q3 2026 at 5,186,534 shares, worth US$54.0M. Across 4 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,186,534 shares valued at US$54.0M — an increase of 1,295,515 shares quarter over quarter.. Notable position changes include a 53% increase in Q2 2026 (shares were roughly flat over the following quarter), a 33% increase in Q3 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.55M | $13.33M | New |
| Q1 2026 | 2.55M | $23.22M | Hold |
| Q2 2026 | 3.89M | $40.12M | Add |
| Q3 2026 | 5.19M | $53.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMMX and 13F data
IMMX (IMMIX BIOPHARMA INC) is a Health Care company. 95 other funds we track also report a position in IMMX — the largest reported positions include Saturn V Capital Management LP (US$48.0M), Deep Track Capital, LP (US$28.6M), Opaleye Management Inc. (US$24.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMMX
- Saturn V Capital Management LP 4.66M sh · $48.03M · Q2 2026
- Deep Track Capital, LP 2.77M sh · $28.61M · Q2 2026
- Opaleye Management Inc. 2.35M sh · $24.18M · Q2 2026
- GREAT POINT PARTNERS LLC 1.28M sh · $13.17M · Q2 2026
- Velan Capital Investment Management LP 1.08M sh · $11.19M · Q2 2026
- Bleichroeder LP 1.00M sh · $10.40M · Q3 2026
- Logos Global Management LP 1.00M sh · $10.31M · Q2 2026
- Blue Owl Capital Holdings LP 602.05K sh · $6.26M · Q3 2026
- Monashee Investment Management LLC 450.00K sh · $4.68M · Q3 2026
- KVP Capital Advisors, LP 230.42K sh · $2.38M · Q2 2026
- Imprint Wealth LLC 26.23K sh · $270.46K · Q2 2026
More on EVENTIDE ASSET MANAGEMENT, LLC
FAQ
How long has EVENTIDE ASSET MANAGEMENT, LLC held IMMX?
EVENTIDE ASSET MANAGEMENT, LLC has disclosed IMMX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is EVENTIDE ASSET MANAGEMENT, LLC's current position in IMMX?
As of Q3 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 5.19M shares of IMMX (IMMIX BIOPHARMA INC), valued at $53.97M, representing 0.76% of its reported portfolio and ranking #40.
Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling IMMX?
In the latest 13F filing (Q3 2026), EVENTIDE ASSET MANAGEMENT, LLC increased its position in IMMX. The position peaked in Q3 2026 at 5.19M shares.
Which other funds hold IMMX?
Other major institutional holders of IMMX include Saturn V Capital Management LP, Deep Track Capital, LP, Opaleye Management Inc., among 95 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.